🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this interventional study is to describe the care pathway follo...
Status
Not Yet Recruiting
Location
ROSELA _ Médecins du Monde
Start Date
2026-09
Trial ID
NCT07788599
Treatments Being Tested
The goal of this prospective study is to explore the safety and preliminary...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-01-15
Trial ID
NCT06775743
Treatments Being Tested
This study will compare the plasma concentration x time curve or Area Under...
Status
Terminated
Location
Christiana Care
Start Date
2020-06-16
Trial ID
NCT04183452
Treatments Being Tested
The purpose of this study is to determine if the addition of apalutamide to...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2015-11-27
Trial ID
NCT02489318
Treatments Being Tested
The primary objective of the study is to compare sacituzumab tirumotecan co...
Status
Recruiting
Location
Mayo Clinic in Arizona - Phoenix ( Site 0147)
Start Date
2023-12-15
Trial ID
NCT06170788
Treatments Being Tested
Currently, the world is facing the challenge of population aging. At this s...
Status
Unknown
Location
Fundación Las Rosas
Start Date
2024-06-01
Trial ID
NCT06787820
Treatments Being Tested
Comparison of olaparib vs. physician's choice of single agent standard of c...
Status
Completed
Location
Research Site
Start Date
2015-02-06
Trial ID
NCT02282020
Treatments Being Tested
This research is being done to determine if investigators can change skin f...
Status
Recruiting
Location
Johns Hopkins School of Medicine, Dermatology Department
Start Date
2015-01-07
Trial ID
NCT01964859
Treatments Being Tested
To seek the efficacy signals of trastuzumab in combination with chemotherap...
Status
Unknown
Location
Beijing Cancer Hospital
Start Date
2017-07-01
Trial ID
NCT03185988
A Double-Masked, Randomized, Placebo-Controlled Study of the Safety, Tolera...
Status
Active Not Recruiting
Location
Beverly Hills Institute of Ophthalmology
Start Date
2025-01-10
Trial ID
NCT06852768
Treatments Being Tested